MBEHQ, depigmenting agent used in the treatment of extensive vitiligo, works by inhibiting the enzyme tyrosinase, which is involved in the production of melanin in the skin, leading to the lightening of the skin in areas affected by vitiligo. This evidence concerns the gene TYR and vitiligo.